Cypherpunk Technologies Inc., a company focused on privacy technology, will announce its third quarter 2026 financial results on November 16, 2026. The company will host a live audio discussion on X Spaces at 9:00 a.m. ET, accessible to the public via their X profile. Cypherpunk advances internet privacy through mining and investing in Zcash and developing cancer therapies via its subsidiary Leap Therapeutics. Investors and interested parties can listen live or access a replay on the company's website and X profile.
Cypherpunk Technologies' upcoming Q3 2026 financial results announcement provides context for readers following technology companies. For readers following technology stocks, here is Pluang's market snapshot as of Nov 10, 2026 18:12 WIB: out of 150 priced US technology stocks, 51 rose and 89 fell today. Notable movers include Kaltura Inc (KLTR) at USD 1.65 with a 15.38% increase and a typical hold time of 22 days, Grab Holdings Ltd. (GRAB) at USD 3.23 down 6.10% with 99% sell order activity and a typical hold time of 96 days, and ASE Technology Holding Co Ltd (ASX) at USD 36.43 up 6.02% with 57% buy order activity and a typical hold time of 50 days.
The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...
Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...
PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...
Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
